Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 16/20 | 0.52 |
| ▸ | CNR2 | P34972 | 1/20 | 0.52 |
| ▸ | SRC | P12931 | 2/20 | 0.50 |
| ▸ | GRM5 | P41594 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4713165 | 0.90 | SRC (0.47) | CNR1CNR2SRCGRM5 | |
| SCHEMBL4711471 | 0.86 | CNR1 (0.64) | CNR1CNR2 | |
| SCHEMBL4711661 | 0.84 | CNR1 (0.71) | CNR1CNR2 | |
| SCHEMBL4714926 | 0.80 | SRC (0.47) | SRC | |
| SCHEMBL4715388 | 0.78 | CNR1 (0.49) | CNR1CNR2SRCGRM5 | |
| SCHEMBL4715084 | 0.76 | CNR1 (0.52) | CNR1CNR2SRC | |
| SCHEMBL4713271 | 0.76 | CNR1 (0.56) | CNR1CNR2 | |
| SCHEMBL4712094 | 0.74 | GRM5 (0.49) | CNR1CNR2GRM5 | |
| SCHEMBL4714457 | 0.73 | CNR1 (0.62) | CNR1CNR2 | |
| SCHEMBL4713168 | 0.73 | SRC (0.47) | SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040214856-A1 | Cannabinoid receptor ligands and uses thereof | PFIZER INC | 2004-10-28 | — | — | US | claimed |
| EP-1622903-B1 | CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | PFIZER PROD INC (US) | 2008-10-01 | — | — | EP | disclosed |
| EP-1622903-A1 | CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | Pfizer Products Inc. (US) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004094421-A1 | CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | PFIZER PRODUCTS INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| US-20040214856-A1 | Cannabinoid receptor ligands and uses thereof | PFIZER INC | 2004-10-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214856-A1 | Cannabinoid receptor ligands and uses thereof | CNR1, CNR2, GPR18 | CNR1 1/4885CNR2 2/4885SRC 1876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.